FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Braslyn Ltd.

2. Date of Event Requiring Statement (MM/DD/YYYY)
10/26/2018 

3. Issuer Name and Ticker or Trading Symbol

Esperion Therapeutics, Inc. [ESPR]

(Last)        (First)        (Middle)

CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

NEW PROVIDENCE, C5        

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   1401000   D   (1)  
Common Stock   1201250   D   (2)  
Common Stock   100   D   (3)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Call Option   10/25/2018   3/15/2019   Common Stock   100000   $50.00   D   (2)  
Call Option   10/25/2018   3/15/2019   Common Stock   70000   $60.00   D   (2)  

Explanation of Responses:
(1)  These securities are owned directly by Braslyn Ltd. ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC ("Boxer Capital"), (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) Tuesday Thirteen Inc. ("Tuesday Thirteen") and (v) Joseph C. Lewis (collectively, the "Boxer Group"), and indirectly by Joseph C. Lewis. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein.
(2)  These securities are owned directly by Boxer Capital and indirectly by Boxer Management and Joseph C. Lewis.
(3)  These securities are owned directly by Tuesday Thirteen and indirectly by Joseph C. Lewis.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Braslyn Ltd.
CAY HOUSE
EP TAYLOR DRIVE N7776, LYFORD CAY
NEW PROVIDENCE, C5 

X

Boxer Asset Management Inc.
CAY HOUSE
EP TAYLOR DRIVE N7776, LYFORD CAY
NEW PROVIDENCE, C5 

X

Tuesday Thirteen Inc.
CAY HOUSE,
EP TAYLOR DRIVE N7776, LYFORD CAY
NEW PROVIDENCE, C5 

X

LEWIS JOSEPH
CAY HOUSE
EP TAYLOR DRIVE N7776, LYFORD CAY
NEW PROVIDENCE, C5 

X

Boxer Capital, LLC
11682 EL CAMINO REAL, SUITE 320
SAN DIEGO, CA 92130

X


Signatures
Braslyn Ltd., By: /s/ Joseph C. Lewis, Director 10/30/2018
** Signature of Reporting Person Date

Boxer Capital, LLC, By: /s/ Aaron I. Davis, Chief Executive Officer 10/30/2018
** Signature of Reporting Person Date

Boxer Asset Management Inc., By: /s/ Jason C. Callender, Director 10/30/2018
** Signature of Reporting Person Date

Tuesday Thirteen Inc., By: /s/ Joseph C. Lewis, Director 10/30/2018
** Signature of Reporting Person Date

/s/ Joseph C. Lewis 10/30/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Esperion Therapeutics Charts.
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Esperion Therapeutics Charts.